Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 6,500 shares at $86.02 ($559K) on 2017-11-30, disclosed to the SEC on 2017-12-04.
Open-market sale of $559k HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |
| HSKA | SELL | 2015-11-25 | $48K | — | Filing → |